G. Cheymol

发表

Comparative Pharmacokinetics of Intravenous Propranolol in Obese and Normal Volunteers

J. Barré, G. Cheymol, J. Poirier, 1987, Journal of clinical pharmacology.

Amiodarone pharmacokinetics in coronary patients: Differences between acute and one-month chronic dosing

P. Coumel, G. Cheymol, J. Poirier, 2010, European Journal of Drug Metabolism and Pharmacokinetics.

Suppression of arrhythmias within hours after a single oral dose of amiodarone and relation to plasma and myocardial concentrations.

P. Coumel, P. Maison-Blanche, P. Menasche, 1985, The American journal of cardiology.

Optimisation of Itraconazole Therapy Using Target Drug Concentrations

G. Cheymol, J. Poirier, Georges Cheymol, 1998, Clinical pharmacokinetics.

DRUG PHARMACOKINETICS IN THE OBESE *

G. Cheymol, 1988, Fundamental & clinical pharmacology.

DRUG PHARMACOKINETICS IN THE OBESE

G. Cheymol, 1988 .

Reproducibility of the model of induced ventricular tachycardia in conscious dogs with infarction.

L. Vernhet, J. Davy, G. Cheymol, 1993, Journal of pharmacological and toxicological methods.

Arrhythmogenic activities of antiarrhythmic drugs in conscious hypokalemic dogs with atrioventricular block: comparison between quinidine, lidocaine, flecainide, propranolol and sotalol.

J. Davy, G. Cheymol, J. Poirier, 1991, The Journal of pharmacology and experimental therapeutics.

Electrophysiological effects of cetirizine, astemizole and d‐sotalol in a canine model of long QT syndrome

G. Cheymol, P. Jaillon, J. Weissenburger, 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Pharmacokinetics of β-adrenoceptor blockers in obese and normal volunteers

P. Carrupt, B. Testa, E. Snoeck, 1997 .

Pharmacokinetic study and cardiovascular monitoring of nebivolol in normal and obese subjects

E. Snoeck, J. Levron, G. Cheymol, 1997, European Journal of Clinical Pharmacology.

Methods and limitations of an experimental model of long QT syndrome.

J. Davy, G. Cheymol, L. Cynober, 1991, Journal of pharmacological methods.

Combination of Sotalol and Quinidine in a Canine Model of Torsades de Pointes

J. Davy, G. Cheymol, J. Poirier, 1998, Journal of cardiovascular electrophysiology.

Pharmacokinetics of intravenous bisoprolol in obese and non-obese volunteers

G. Cheymol, J. Poirier, F. Hugues, 2004, European Journal of Clinical Pharmacology.

[Pharmacokinetic study of sotalol administered intravenously to healthy men. Application of high performance liquid chromatography (author's transl)].

G. Cheymol, J. Poirier, P. Jaillon, 1981, Therapie.

Experimental Arrhythmogenicity of Quinidine: Effects of Dose and Route of Administration

J. Davy, G. Cheymol, J. Poirier, 1989 .

Pharmacokinetics of beta-adrenoceptor blockers in obese and normal volunteers.

P. Carrupt, B. Testa, E. Snoeck, 1997, British journal of clinical pharmacology.

Cardiovascular and β-adrenergic blocking effects of timolol

G. Cheymol, H. Schmitt, P. Mouille, 1976 .

Rapid and sensitive column liquid chromatographic determination of sotalol in plasma.

G. Cheymol, J. Poirier, M. Lebot, 1989, Journal of chromatography.

Estimation of the absolute oral bioavailability of pindolol by two analytical methods

G. Cheymol, M. Guerret, J. Aubry, 2004, European Journal of Clinical Pharmacology.

COMPARATIVE HEMODYNAMIC STUDY OF A NEW AMINOSTEROID: LND‐623 WITH ITS 20α‐ISOMER: LND‐369, AND WITH DIGOXIN AND DIGOXIGENIN‐RHAMNOSIDE IN THE ANESTHETIZED DOG

G. Cheymol, J. Poirier, P. Jaillon, 1989, Fundamental & clinical pharmacology.

Plasma itraconazole concentrations in patients with neutropenia: advantages of a divided daily dosage regimen.

G. Cheymol, J. Poirier, P. Tilleul, 1997, Therapeutic drug monitoring.

A rapid and specific liquid chromatographic assay for the determination of itraconazole and hydroxyitraconazole in plasma.

G. Cheymol, J. Poirier, 1997, Therapeutic drug monitoring.

Determination of Itraconazole and Its Active Metabolite in Plasma by Column Liquid Chromatography

G. Cheymol, J. Poirier, P. Descamps, 1994, Therapeutic drug monitoring.

[Prevention of aspergillosis with itraconazole in neutropenic patients: importance of drug monitoring].

G. Cheymol, J. Poirier, 1999, Bulletin de l'Academie nationale de medecine.

Marked intra- and inter-patient variability of itraconazole steady state plasma concentrations.

G. Cheymol, J. Poirier, F. Isnard, 1996, Therapie.

Pharmacokinetics of intravenous and oral pentoxifylline in healthy volunteers and in cirrhotic patients

G. Cheymol, J. Poirier, R. Poupon, 1990, Clinical pharmacology and therapeutics.

Rapid and sensitive high-performance liquid chromatographic determination of bisoprolol in plasma and urine.

G. Cheymol, J. Poirier, P. Jaillon, 1988, Journal of chromatography.

Study of the bioavailability of pindolol in malabsorption syndromes.

G. Cheymol, Y. le Quintrec, D. Evard, 1984, British journal of clinical pharmacology.

Clinical Pharmacokinetics of Drugs in Obesity

G Cheymol, G. Cheymol, 1993, Clinical pharmacokinetics.

[Hepatitis and pancreatitis due to indalpine].

G. Cheymol, Y. Calmus, M. Biour, 1985, Gastroenterologie clinique et biologique.

The pharmacokinetics of d-sotalol and d,l-sotalol in healthy volunteers

G. Cheymol, J. Poirier, B. Lecocq, 2004, European Journal of Clinical Pharmacology.

[Hepatotoxicity of drugs. Update of the data bank on hepatic involvement and the responsible drugs].

M Biour, G Cheymol, G. Cheymol, 1989, Gastroenterologie clinique et biologique.

Rapid and sensitive liquid chromatographic assay of mefenamic acid in plasma.

G. Cheymol, J. Poirier, M. Lebot, 1992, Therapeutic drug monitoring.

Effects of Obesity on Pharmacokinetics

G. Cheymol, 2000 .

The Influence of Vasoactive Agents on Metabolic Activity of the Liver in Cirrhosis: A Study of the Effects of Posterior Pituitary Extract, Vasopressin, and Somatostatin

G. Cheymol, R. Poupon, P. Jaillon, 1984, Hepatology.

INCIDENCE OF NSAID-RELATED, SEVERE GASTROINTESTINAL BLEEDING

G. Cheymol, M. Biour, J. Grangé, 1987, The Lancet.

Study of urinary excretion of butobarbitone in man in relation to the percentage of ideal body weight.

G. Cheymol, J. Dry, J. Besson, 1979, British journal of clinical pharmacology.

Analysis of encainide and its three major metabolites in plasma by column liquid chromatography.

G. Cheymol, J. Poirier, M. Lebot, 1990, Journal of chromatography.

[Study in man of butobarbital pharmacokinetics, under polygraphic monitoring].

J. Willer, G. Cheymol, R. Gomeni, 1978, Therapie.

Contents, Vol. 8, 1963

H. Selye, W. Burkard, B. Brodie, 1963 .

[A trisubstituted derivative of orthophosphoric acid possessing powerful anticholinesterase activity].

G. Cheymol, G. Olive, 1967, Annales pharmaceutiques francaises.

Long-term efficacy and safety of oral encainide in the treatment of chronic ventricular ectopic activity: relationship to plasma concentrations--a French multicenter trial.

P. Coumel, J. Valty, G. Cheymol, 1985, American heart journal.

Comparison of Propranolol and Sotalol Pharmacokinetics in Obese Subjects

J. Barré, G. Cheymol, J. Poirier, 1990, The Journal of pharmacy and pharmacology.

Pharmacokinetic characteristics of bornaprolol in healthy volunteers.

G. Cheymol, P. Jaillon, B. Lecoq, 1990, Xenobiotica; the fate of foreign compounds in biological systems.

[Comparison of beta-blocking agents pharmacokinetics in obese and non-obese subjects].

G. Cheymol, 1990, Bulletin de l'Academie nationale de medecine.

Cardiac electrophysiologic properties of dl-propranolol, d-propranolol, l-propranolol and dl-pindolol in anesthetized dogs.

G. Cheymol, P. Jaillon, J. Weissenburger, 1980, The Journal of pharmacology and experimental therapeutics.

[Cardiovascular and hemodynamic effects of two derivatives of metoclopramide (bromopride and MUS 1880)].

G. Cheymol, P. Mouille, C. Gadbin, 1977, Annales Pharmaceutiques Françaises.

Pharmacological effects of two new -adrenoceptor blocking drugs: Kö 1366 and Kö 1313.

G. Cheymol, H. Schmitt, C. Honnorat, 1972, European journal of pharmacology.

The pharmacokinetics of dexfenfluramine in obese and non-obese subjects.

J Weissenburger, G Cheymol, G. Cheymol, 1995, British journal of clinical pharmacology.

Comparative dromotropic activity of timolol and propranolol in anesthetized dogs.

G. Cheymol, P. Jaillon, J. Weissenburger, 1978, European journal of pharmacology.

Pharmacological investigation of cardiovascular and haemodynamic effects of salts of ioxitalamic acid in anaesthetized dogs.

G. Cheymol, P. Mouille, D. Grasland, 1977, Arzneimittel-Forschung.

[The pharmacokinetic basis of of the undesirable effects of drugs in the aged subject].

G. Cheymol, M. Biour, 1983, Therapie.

β and α‐Adrenoceptor Antagonism by Medroxalol in Healthy Volunteers: Relationship to Dose and Plasma Concentration

G. Cheymol, P. Schechter, J. Koch-weser, 1982, Journal of cardiovascular pharmacology.

Study of cyclosporin A blood level during the early post-liver-transplantation period.

A. Lienhart, B. Nordlinger, P. Balladur, 1993, Therapie.

[Electrophysiological effects of intravenous sotalol. Relation with plasma levels].

J. Valty, G. Cheymol, J. Poirier, 1985, Archives des maladies du coeur et des vaisseaux.

Kinetics of medroxalol, a β‐ and α‐adrenoceptor antagonist

G. Cheymol, P. Schechter, J. Koch-weser, 1983 .

Kinetics of medroxalol, a beta- and alpha-adrenoceptor antagonist.

G. Cheymol, P. Schechter, J. Koch-weser, 1983, Clinical pharmacology and therapeutics.

[Comparative study of chronotropic and inotropic effects of different beta adrenolytic drugs].

G. Cheymol, M. Laubie, H. Schmitt, 1972, Comptes rendus des seances de la Societe de biologie et de ses filiales.

HEPATOX: a microcomputer database of drug-induced hepatic injury.

G. Cheymol, Y. Calmus, M. Biour, 1989, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology.

[Merits of the assay of plasma catecholamines in a glucagon test to diagnosis of pheochromocytoma (author's transl)].

G. Cheymol, P. Jaillon, M. Cloarec, 1978, La Nouvelle presse medicale.

Comparison of the Cardiac Electrophysiological Effects of Flecainide and Hydroquinidine in Anesthetized Dog: Concentration‐Response Relationship

J. Davy, G. Cheymol, J. Poirier, 1990, Journal of cardiovascular pharmacology.

Effects of the beta-adrenergic blocking agents propranolol and timolol on canine cardiac refractory periods.

G. Cheymol, P. Jaillon, J. Weissenburger, 1979, European journal of pharmacology.

Simultaneous study of the pharmacokinetics of intravenous and oral nicardipine using a stable isotope

G. Cheymol, M. Hubert, M. Guerret, 2004, European Journal of Clinical Pharmacology.